Predisposing Factors and Incidence of Venous Thromboembolism among Hospitalized Patients with Sickle Cell Disease

被引:2
作者
Ziyadah, Mohammed S. [1 ]
Mansory, Eman M. [2 ,3 ]
Alahwal, Hatem M. [2 ,3 ]
Bahashwan, Salem M. [2 ,3 ]
Almohammadi, Abdullah T. [2 ,3 ]
Radhwi, Osman O. [2 ,3 ]
Alghamdi, Talal [1 ]
Khan, Shahida A. [4 ,5 ]
Almashjary, Majed N. [3 ,5 ]
Barefah, Ahmed S. [2 ,3 ]
机构
[1] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Fac Med, Dept Internal Med, Jeddah 21589, Saudi Arabia
[2] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Fac Med, Hematol Dept, Jeddah 21589, Saudi Arabia
[3] King Abdulaziz Univ, King Fahd Med Res Ctr, Hematol Res Unit, Jeddah 21589, Saudi Arabia
[4] King Abdulaziz Univ, King Fahd Med Res Ctr, Appl Med Nutr Grp, Jeddah 21589, Saudi Arabia
[5] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Sci, Jeddah 21589, Saudi Arabia
关键词
sickle cell disease; venous thromboembolic events; deep vein thrombosis; pulmonary embolism; FACTOR EXPRESSION; PREGNANT-WOMEN; POTENTIAL ROLE; COAGULATION; ACTIVATION; ABNORMALITIES; PROPHYLAXIS; MANAGEMENT; HEPARIN; ANEMIA;
D O I
10.3390/jcm12206498
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Though patients with sickle cell disease (SCD) are at risk of developing venous thromboembolism (VTE), clear estimates of its incidence and predisposing factors in hospitalized SCD patients are not available. Therefore, this issue was addressed to facilitate an early diagnosis and initiate appropriate prophylactic and treatment strategies. A retrospective observational study was conducted on patients with SCD who were admitted to an academic center in Saudi Arabia over a 10-year period. We identified 1054 admissions of 394 patients with SCD. Of the 3% of patients identified with VTE, 50% experienced pulmonary embolism (PE), 34.3% exhibited deep vein thrombosis (DVT), 6.3% exhibited cerebral vein thrombosis, and 9.4% showed other forms of VTE. In pregnant SCD patients, 6.4% developed a VTE event during their hospital admission. Of the risk factors, high white blood cell count, length of stay, and presence of any additional risk factor for VTE was associated significantly with higher risk of VTE. In our study, this risk seems to be much lower, which is likely attributed to the use of VTE prophylactic strategies implemented in our center. Nevertheless, further studies are needed to establish the ideal prophylactic strategy in patients with SCD.
引用
收藏
页数:11
相关论文
共 42 条
  • [1] Pregnancy-related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data
    Agarwal, Shreya
    Stanek, Joseph R.
    Vesely, Sara K.
    Creary, Susan E.
    Cronin, Robert M.
    Roe, Andrea H.
    O'Brien, Sarah H.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (11) : 1677 - 1684
  • [2] Al-Gahtani F.H., 2016, J. Hematol. Thrombo. Dis, V4, P1000254, DOI [10.4172/2329-8790.1000254, DOI 10.4172/2329-8790.1000254]
  • [3] Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia - lessons learned for prophylaxis
    Alkindi, Salam
    Al-Ghadani, Anwaar R.
    Al-Zeheimi, Samah R.
    Alkindi, Said Y.
    Fawaz, Naglaa
    Ballas, Samir K.
    Pathare, Anil, V
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (12)
  • [4] Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011-2015
    Alsaeed, Eman S.
    Farhat, Ghada N.
    Assiri, Abdullah M.
    Memish, Ziad
    Ahmed, Elawad M.
    Saeedi, Mohammad Y.
    Al-Dossary, Mishal F.
    Bashawri, Hisham
    [J]. JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2018, 7 : S41 - S47
  • [5] Ataga Kenneth I, 2007, Hematology Am Soc Hematol Educ Program, P91
  • [6] Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state
    Bayazit, AK
    Kilinç, Y
    [J]. PEDIATRICS INTERNATIONAL, 2001, 43 (06) : 592 - 596
  • [7] Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion
    Belcher, JD
    Marker, PH
    Weber, JP
    Hebbel, RP
    Vercellotti, GM
    [J]. BLOOD, 2000, 96 (07) : 2451 - 2459
  • [8] Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells
    Beltrán, AE
    Concepción, F
    Manzanares, D
    Garrido, G
    Glaria, LA
    Rojas, A
    [J]. ARCHIVES OF MEDICAL RESEARCH, 1999, 30 (02): : 116 - 119
  • [9] Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality
    Brunson, Ann
    Lei, Amy
    Rosenberg, Aaron S.
    White, Richard H.
    Keegan, Theresa
    Wun, Ted
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (02) : 319 - 326
  • [10] Pulmonary hypertension and nitric oxide depletion in sickle cell disease
    Bunn, H. Franklin
    Nathan, David G.
    Dover, George J.
    Hebbel, Robert P.
    Platt, Orah S.
    Rosse, Wendell F.
    Ware, Russell E.
    [J]. BLOOD, 2010, 116 (05) : 687 - 692